Melanoma Vaccine

Melanoma Vaccine Article

Information resource about cancer clinical trials Melanoma Clinical Trials In active followup Melanoma Clinical Trials Know, which explains the possible benefits and risks of clinical trials for melanoma and other cancer indications, to be notified when new melanoma clinical trials at the NIH Clinical Center in Bethesda, Md NCI accepts referrals to melanoma clinical trials at the NIH Clinical Center in Bethesda, Md NCI accepts referrals to melanoma clinical trials from the clinical trials database at Mayo Clinic Mayo's clinical trials include experimental treatments, often unavailable Melanoma Clinical Trials Trial Title Condition Location Melanoma Clinical Trials Trial Title Condition Location Melanoma Clinical Trials at The Norris Cotton Cancer Center Clinical Trials Search Cancer Prevention Studies What is a Clinical Trial? Diseases Clinical Trials FAQ Resource Links For information on clinical trials sponsored by Vical and others, please see the Thyroid and Parathyroid Gastrointestinal Cancers Metastatic Tumors Clinical Trials Breast Cancer Forms Division Home FIND A DOCTOR Clinical Trials Cancer Information Cancer Center Home Cancer Care and Prevention Professionals Melanoma Trials All Cancer Clinical Trials Urological Cancer Clincal Trials Lung Cancer Lymphoma Melanoma Pediatric Cancers Prostate Cancer All cancer types The clinical trials

Melanoma Vaccine News

Vaccine could aid melanoma patients

New York - A vaccine currently undergoing clinical trials appears to prolong recurrence-free survival in resected stage III melanoma patients, Jean-Claude Bystryn, M.D., said. The vaccine may also improve overall survival of melanoma patients, he added. "I think this is an exciting but still

Melanoma vaccine possible, say dermatologists.

MELANOMA VACCINE POSSIBLE, SAY DERMATOLOGISTS Persons suffering from melanoma may be getting relief in the form of a vaccine developed from substances shed from melanoma cells themselves. Developers of the vaccine say their findings indicate either initial or increased responses in half the

Melanoma vaccine promising for intermediate outcomes

MELANOMA Venice, Italy - A vaccine made from two lines of lysed human melanoma cells combined with an immunologic adjuvant appears to reduce the rates of recurrence and death in some patients with Stage Ila melanoma. "In a multicenter study, we showed that in this group of patients, administering

Vaccine shows modest benefit for some with early melanoma

Phoenix - At a recent melanoma conference, cancer researchers reported that Melacine, a novel melanoma vaccine, of fered slight improvement in the treatment of tumors less than 3 mm thick. Once researchers have thoroughly analyzed the data, the vaccine - recently approved in Canada - may be

Melanoma vaccine improves quality of life

In the making for more than 14 years, a melanoma therapeutic vaccine discovered by an American cancer researcher has met regulatory requirements in Canada and should soon be available to patients there. In November the Canadian Health Protection Branch granted the vaccine, known as Melacine,